nodes	percent_of_prediction	percent_of_DWPC	metapath
Nabumetone—MPO—Alzheimer's disease	0.367	0.492	CbGaD
Nabumetone—PTGS1—Alzheimer's disease	0.241	0.323	CbGaD
Nabumetone—PTGS2—Alzheimer's disease	0.138	0.185	CbGaD
Nabumetone—Melatonin—MT3—Alzheimer's disease	0.00233	0.446	CrCbGaD
Nabumetone—MPO—blood vessel—Alzheimer's disease	0.00144	0.189	CbGeAlD
Nabumetone—Melatonin—CALM1—Alzheimer's disease	0.00111	0.213	CrCbGaD
Nabumetone—MPO—forebrain—Alzheimer's disease	0.000758	0.0997	CbGeAlD
Nabumetone—PTGS1—blood vessel—Alzheimer's disease	0.000682	0.0896	CbGeAlD
Nabumetone—PTGS2—blood vessel—Alzheimer's disease	0.000652	0.0857	CbGeAlD
Nabumetone—Arrhythmia—Galantamine—Alzheimer's disease	0.000613	0.0032	CcSEcCtD
Nabumetone—Weight increased—Donepezil—Alzheimer's disease	0.000605	0.00316	CcSEcCtD
Nabumetone—Gastritis—Rivastigmine—Alzheimer's disease	0.000604	0.00315	CcSEcCtD
Nabumetone—Melatonin—MPO—Alzheimer's disease	0.000604	0.116	CrCbGaD
Nabumetone—Asthma—Memantine—Alzheimer's disease	0.000603	0.00315	CcSEcCtD
Nabumetone—Dysphagia—Memantine—Alzheimer's disease	0.000603	0.00315	CcSEcCtD
Nabumetone—Weight decreased—Donepezil—Alzheimer's disease	0.000601	0.00314	CcSEcCtD
Nabumetone—Hyperglycaemia—Donepezil—Alzheimer's disease	0.000599	0.00313	CcSEcCtD
Nabumetone—Pneumonia—Donepezil—Alzheimer's disease	0.000596	0.00311	CcSEcCtD
Nabumetone—Pancreatitis—Memantine—Alzheimer's disease	0.000592	0.00309	CcSEcCtD
Nabumetone—Depression—Donepezil—Alzheimer's disease	0.000591	0.00308	CcSEcCtD
Nabumetone—Dysphagia—Rivastigmine—Alzheimer's disease	0.00059	0.00308	CcSEcCtD
Nabumetone—Flatulence—Galantamine—Alzheimer's disease	0.000589	0.00307	CcSEcCtD
Nabumetone—Sweating increased—Memantine—Alzheimer's disease	0.000588	0.00307	CcSEcCtD
Nabumetone—Angina pectoris—Memantine—Alzheimer's disease	0.000588	0.00307	CcSEcCtD
Nabumetone—Tension—Galantamine—Alzheimer's disease	0.000586	0.00306	CcSEcCtD
Nabumetone—Acute coronary syndrome—Donepezil—Alzheimer's disease	0.000584	0.00305	CcSEcCtD
Nabumetone—Renal failure—Donepezil—Alzheimer's disease	0.000582	0.00304	CcSEcCtD
Nabumetone—Myocardial infarction—Donepezil—Alzheimer's disease	0.000581	0.00303	CcSEcCtD
Nabumetone—Nervousness—Galantamine—Alzheimer's disease	0.00058	0.00303	CcSEcCtD
Nabumetone—Pancreatitis—Rivastigmine—Alzheimer's disease	0.000579	0.00302	CcSEcCtD
Nabumetone—Jaundice—Donepezil—Alzheimer's disease	0.000578	0.00301	CcSEcCtD
Nabumetone—Sweating increased—Rivastigmine—Alzheimer's disease	0.000575	0.003	CcSEcCtD
Nabumetone—Angina pectoris—Rivastigmine—Alzheimer's disease	0.000575	0.003	CcSEcCtD
Nabumetone—Haematuria—Donepezil—Alzheimer's disease	0.000565	0.00295	CcSEcCtD
Nabumetone—Dysuria—Memantine—Alzheimer's disease	0.000564	0.00294	CcSEcCtD
Nabumetone—Tremor—Galantamine—Alzheimer's disease	0.00056	0.00292	CcSEcCtD
Nabumetone—Erectile dysfunction—Memantine—Alzheimer's disease	0.000556	0.0029	CcSEcCtD
Nabumetone—Ill-defined disorder—Galantamine—Alzheimer's disease	0.000554	0.00289	CcSEcCtD
Nabumetone—Anaemia—Galantamine—Alzheimer's disease	0.000552	0.00288	CcSEcCtD
Nabumetone—Dysuria—Rivastigmine—Alzheimer's disease	0.000552	0.00288	CcSEcCtD
Nabumetone—Weight increased—Memantine—Alzheimer's disease	0.000549	0.00287	CcSEcCtD
Nabumetone—Agitation—Galantamine—Alzheimer's disease	0.000549	0.00287	CcSEcCtD
Nabumetone—Weight decreased—Memantine—Alzheimer's disease	0.000546	0.00285	CcSEcCtD
Nabumetone—Hyperglycaemia—Memantine—Alzheimer's disease	0.000544	0.00284	CcSEcCtD
Nabumetone—Erectile dysfunction—Rivastigmine—Alzheimer's disease	0.000544	0.00284	CcSEcCtD
Nabumetone—Pneumonia—Memantine—Alzheimer's disease	0.000541	0.00282	CcSEcCtD
Nabumetone—Malaise—Galantamine—Alzheimer's disease	0.000539	0.00281	CcSEcCtD
Nabumetone—Photosensitivity reaction—Rivastigmine—Alzheimer's disease	0.000539	0.00281	CcSEcCtD
Nabumetone—Weight increased—Rivastigmine—Alzheimer's disease	0.000537	0.0028	CcSEcCtD
Nabumetone—Vertigo—Galantamine—Alzheimer's disease	0.000537	0.0028	CcSEcCtD
Nabumetone—Depression—Memantine—Alzheimer's disease	0.000536	0.0028	CcSEcCtD
Nabumetone—Syncope—Galantamine—Alzheimer's disease	0.000536	0.0028	CcSEcCtD
Nabumetone—Haemoglobin—Donepezil—Alzheimer's disease	0.000535	0.00279	CcSEcCtD
Nabumetone—Weight decreased—Rivastigmine—Alzheimer's disease	0.000534	0.00279	CcSEcCtD
Nabumetone—Stevens-Johnson syndrome—Memantine—Alzheimer's disease	0.000533	0.00278	CcSEcCtD
Nabumetone—Hyperglycaemia—Rivastigmine—Alzheimer's disease	0.000532	0.00278	CcSEcCtD
Nabumetone—Haemorrhage—Donepezil—Alzheimer's disease	0.000532	0.00278	CcSEcCtD
Nabumetone—Acute coronary syndrome—Memantine—Alzheimer's disease	0.00053	0.00277	CcSEcCtD
Nabumetone—Pneumonia—Rivastigmine—Alzheimer's disease	0.000529	0.00276	CcSEcCtD
Nabumetone—Renal failure—Memantine—Alzheimer's disease	0.000529	0.00276	CcSEcCtD
Nabumetone—Palpitations—Galantamine—Alzheimer's disease	0.000528	0.00276	CcSEcCtD
Nabumetone—Myocardial infarction—Memantine—Alzheimer's disease	0.000527	0.00275	CcSEcCtD
Nabumetone—Loss of consciousness—Galantamine—Alzheimer's disease	0.000525	0.00274	CcSEcCtD
Nabumetone—Depression—Rivastigmine—Alzheimer's disease	0.000525	0.00274	CcSEcCtD
Nabumetone—Stevens-Johnson syndrome—Rivastigmine—Alzheimer's disease	0.000522	0.00272	CcSEcCtD
Nabumetone—Cough—Galantamine—Alzheimer's disease	0.000521	0.00272	CcSEcCtD
Nabumetone—Acute coronary syndrome—Rivastigmine—Alzheimer's disease	0.000519	0.00271	CcSEcCtD
Nabumetone—Renal failure—Rivastigmine—Alzheimer's disease	0.000517	0.0027	CcSEcCtD
Nabumetone—Myocardial infarction—Rivastigmine—Alzheimer's disease	0.000516	0.00269	CcSEcCtD
Nabumetone—Hypertension—Galantamine—Alzheimer's disease	0.000516	0.00269	CcSEcCtD
Nabumetone—Haematuria—Memantine—Alzheimer's disease	0.000513	0.00268	CcSEcCtD
Nabumetone—Visual impairment—Donepezil—Alzheimer's disease	0.000513	0.00267	CcSEcCtD
Nabumetone—Anxiety—Galantamine—Alzheimer's disease	0.000507	0.00265	CcSEcCtD
Nabumetone—Discomfort—Galantamine—Alzheimer's disease	0.000503	0.00262	CcSEcCtD
Nabumetone—Agranulocytosis—Memantine—Alzheimer's disease	0.000502	0.00262	CcSEcCtD
Nabumetone—Haematuria—Rivastigmine—Alzheimer's disease	0.000502	0.00262	CcSEcCtD
Nabumetone—Dry mouth—Galantamine—Alzheimer's disease	0.000497	0.0026	CcSEcCtD
Nabumetone—Tinnitus—Donepezil—Alzheimer's disease	0.000496	0.00259	CcSEcCtD
Nabumetone—Confusional state—Galantamine—Alzheimer's disease	0.000492	0.00257	CcSEcCtD
Nabumetone—Haemoglobin—Memantine—Alzheimer's disease	0.000485	0.00253	CcSEcCtD
Nabumetone—Haemorrhage—Memantine—Alzheimer's disease	0.000483	0.00252	CcSEcCtD
Nabumetone—Shock—Galantamine—Alzheimer's disease	0.00048	0.0025	CcSEcCtD
Nabumetone—Thrombocytopenia—Galantamine—Alzheimer's disease	0.000477	0.00249	CcSEcCtD
Nabumetone—Chills—Donepezil—Alzheimer's disease	0.000477	0.00249	CcSEcCtD
Nabumetone—Arrhythmia—Donepezil—Alzheimer's disease	0.000475	0.00248	CcSEcCtD
Nabumetone—Haemoglobin—Rivastigmine—Alzheimer's disease	0.000475	0.00248	CcSEcCtD
Nabumetone—Haemorrhage—Rivastigmine—Alzheimer's disease	0.000472	0.00247	CcSEcCtD
Nabumetone—Hyperhidrosis—Galantamine—Alzheimer's disease	0.000471	0.00246	CcSEcCtD
Nabumetone—Alopecia—Donepezil—Alzheimer's disease	0.00047	0.00245	CcSEcCtD
Nabumetone—Visual impairment—Memantine—Alzheimer's disease	0.000465	0.00243	CcSEcCtD
Nabumetone—Anorexia—Galantamine—Alzheimer's disease	0.000465	0.00243	CcSEcCtD
Nabumetone—Naproxen—PTGS1—Alzheimer's disease	0.00046	0.0881	CrCbGaD
Nabumetone—Erythema multiforme—Memantine—Alzheimer's disease	0.000457	0.00238	CcSEcCtD
Nabumetone—Flatulence—Donepezil—Alzheimer's disease	0.000456	0.00238	CcSEcCtD
Nabumetone—Visual impairment—Rivastigmine—Alzheimer's disease	0.000455	0.00238	CcSEcCtD
Nabumetone—Tension—Donepezil—Alzheimer's disease	0.000454	0.00237	CcSEcCtD
Nabumetone—Melatonin—ESR1—Alzheimer's disease	0.000453	0.0868	CrCbGaD
Nabumetone—Tinnitus—Memantine—Alzheimer's disease	0.00045	0.00235	CcSEcCtD
Nabumetone—Nervousness—Donepezil—Alzheimer's disease	0.00045	0.00235	CcSEcCtD
Nabumetone—Erythema multiforme—Rivastigmine—Alzheimer's disease	0.000447	0.00233	CcSEcCtD
Nabumetone—Insomnia—Galantamine—Alzheimer's disease	0.000441	0.0023	CcSEcCtD
Nabumetone—Tinnitus—Rivastigmine—Alzheimer's disease	0.000441	0.0023	CcSEcCtD
Nabumetone—Paraesthesia—Galantamine—Alzheimer's disease	0.000438	0.00228	CcSEcCtD
Nabumetone—Tremor—Donepezil—Alzheimer's disease	0.000434	0.00226	CcSEcCtD
Nabumetone—Somnolence—Galantamine—Alzheimer's disease	0.000433	0.00226	CcSEcCtD
Nabumetone—Chills—Memantine—Alzheimer's disease	0.000433	0.00226	CcSEcCtD
Nabumetone—Arrhythmia—Memantine—Alzheimer's disease	0.000431	0.00225	CcSEcCtD
Nabumetone—Ill-defined disorder—Donepezil—Alzheimer's disease	0.00043	0.00224	CcSEcCtD
Nabumetone—Dyspepsia—Galantamine—Alzheimer's disease	0.000429	0.00224	CcSEcCtD
Nabumetone—Anaemia—Donepezil—Alzheimer's disease	0.000428	0.00223	CcSEcCtD
Nabumetone—Alopecia—Memantine—Alzheimer's disease	0.000427	0.00223	CcSEcCtD
Nabumetone—Agitation—Donepezil—Alzheimer's disease	0.000426	0.00222	CcSEcCtD
Nabumetone—Chills—Rivastigmine—Alzheimer's disease	0.000424	0.00221	CcSEcCtD
Nabumetone—Decreased appetite—Galantamine—Alzheimer's disease	0.000424	0.00221	CcSEcCtD
Nabumetone—Arrhythmia—Rivastigmine—Alzheimer's disease	0.000422	0.0022	CcSEcCtD
Nabumetone—Fatigue—Galantamine—Alzheimer's disease	0.00042	0.00219	CcSEcCtD
Nabumetone—Malaise—Donepezil—Alzheimer's disease	0.000418	0.00218	CcSEcCtD
Nabumetone—Alopecia—Rivastigmine—Alzheimer's disease	0.000417	0.00218	CcSEcCtD
Nabumetone—Constipation—Galantamine—Alzheimer's disease	0.000417	0.00218	CcSEcCtD
Nabumetone—Vertigo—Donepezil—Alzheimer's disease	0.000416	0.00217	CcSEcCtD
Nabumetone—Syncope—Donepezil—Alzheimer's disease	0.000415	0.00217	CcSEcCtD
Nabumetone—Flatulence—Memantine—Alzheimer's disease	0.000414	0.00216	CcSEcCtD
Nabumetone—Tension—Memantine—Alzheimer's disease	0.000413	0.00215	CcSEcCtD
Nabumetone—MPO—nervous system—Alzheimer's disease	0.000412	0.0541	CbGeAlD
Nabumetone—Nervousness—Memantine—Alzheimer's disease	0.000408	0.00213	CcSEcCtD
Nabumetone—Loss of consciousness—Donepezil—Alzheimer's disease	0.000407	0.00212	CcSEcCtD
Nabumetone—Flatulence—Rivastigmine—Alzheimer's disease	0.000405	0.00211	CcSEcCtD
Nabumetone—Cough—Donepezil—Alzheimer's disease	0.000404	0.00211	CcSEcCtD
Nabumetone—Tension—Rivastigmine—Alzheimer's disease	0.000404	0.00211	CcSEcCtD
Nabumetone—Feeling abnormal—Galantamine—Alzheimer's disease	0.000402	0.0021	CcSEcCtD
Nabumetone—Hypertension—Donepezil—Alzheimer's disease	0.0004	0.00209	CcSEcCtD
Nabumetone—Nervousness—Rivastigmine—Alzheimer's disease	0.000399	0.00208	CcSEcCtD
Nabumetone—Gastrointestinal pain—Galantamine—Alzheimer's disease	0.000399	0.00208	CcSEcCtD
Nabumetone—MPO—central nervous system—Alzheimer's disease	0.000396	0.0521	CbGeAlD
Nabumetone—Tremor—Memantine—Alzheimer's disease	0.000394	0.00206	CcSEcCtD
Nabumetone—Anxiety—Donepezil—Alzheimer's disease	0.000393	0.00205	CcSEcCtD
Nabumetone—Ill-defined disorder—Memantine—Alzheimer's disease	0.00039	0.00204	CcSEcCtD
Nabumetone—Discomfort—Donepezil—Alzheimer's disease	0.000389	0.00203	CcSEcCtD
Nabumetone—PTGS2—embryo—Alzheimer's disease	0.000389	0.0511	CbGeAlD
Nabumetone—Anaemia—Memantine—Alzheimer's disease	0.000389	0.00203	CcSEcCtD
Nabumetone—Agitation—Memantine—Alzheimer's disease	0.000386	0.00202	CcSEcCtD
Nabumetone—Dry mouth—Donepezil—Alzheimer's disease	0.000386	0.00201	CcSEcCtD
Nabumetone—Abdominal pain—Galantamine—Alzheimer's disease	0.000385	0.00201	CcSEcCtD
Nabumetone—Body temperature increased—Galantamine—Alzheimer's disease	0.000385	0.00201	CcSEcCtD
Nabumetone—Tremor—Rivastigmine—Alzheimer's disease	0.000385	0.00201	CcSEcCtD
Nabumetone—Ill-defined disorder—Rivastigmine—Alzheimer's disease	0.000382	0.00199	CcSEcCtD
Nabumetone—Confusional state—Donepezil—Alzheimer's disease	0.000381	0.00199	CcSEcCtD
Nabumetone—Anaemia—Rivastigmine—Alzheimer's disease	0.00038	0.00198	CcSEcCtD
Nabumetone—Malaise—Memantine—Alzheimer's disease	0.000379	0.00198	CcSEcCtD
Nabumetone—Agitation—Rivastigmine—Alzheimer's disease	0.000378	0.00197	CcSEcCtD
Nabumetone—Oedema—Donepezil—Alzheimer's disease	0.000378	0.00197	CcSEcCtD
Nabumetone—Vertigo—Memantine—Alzheimer's disease	0.000378	0.00197	CcSEcCtD
Nabumetone—Syncope—Memantine—Alzheimer's disease	0.000377	0.00197	CcSEcCtD
Nabumetone—Leukopenia—Memantine—Alzheimer's disease	0.000376	0.00196	CcSEcCtD
Nabumetone—Shock—Donepezil—Alzheimer's disease	0.000372	0.00194	CcSEcCtD
Nabumetone—Palpitations—Memantine—Alzheimer's disease	0.000372	0.00194	CcSEcCtD
Nabumetone—Malaise—Rivastigmine—Alzheimer's disease	0.000371	0.00194	CcSEcCtD
Nabumetone—Thrombocytopenia—Donepezil—Alzheimer's disease	0.00037	0.00193	CcSEcCtD
Nabumetone—Vertigo—Rivastigmine—Alzheimer's disease	0.00037	0.00193	CcSEcCtD
Nabumetone—Loss of consciousness—Memantine—Alzheimer's disease	0.00037	0.00193	CcSEcCtD
Nabumetone—Syncope—Rivastigmine—Alzheimer's disease	0.000369	0.00192	CcSEcCtD
Nabumetone—Cough—Memantine—Alzheimer's disease	0.000367	0.00191	CcSEcCtD
Nabumetone—Hyperhidrosis—Donepezil—Alzheimer's disease	0.000365	0.00191	CcSEcCtD
Nabumetone—Palpitations—Rivastigmine—Alzheimer's disease	0.000363	0.0019	CcSEcCtD
Nabumetone—Hypertension—Memantine—Alzheimer's disease	0.000363	0.00189	CcSEcCtD
Nabumetone—Loss of consciousness—Rivastigmine—Alzheimer's disease	0.000361	0.00189	CcSEcCtD
Nabumetone—Anorexia—Donepezil—Alzheimer's disease	0.00036	0.00188	CcSEcCtD
Nabumetone—PTGS1—forebrain—Alzheimer's disease	0.00036	0.0473	CbGeAlD
Nabumetone—Hypersensitivity—Galantamine—Alzheimer's disease	0.000359	0.00187	CcSEcCtD
Nabumetone—Cough—Rivastigmine—Alzheimer's disease	0.000359	0.00187	CcSEcCtD
Nabumetone—Anxiety—Memantine—Alzheimer's disease	0.000357	0.00186	CcSEcCtD
Nabumetone—Hypertension—Rivastigmine—Alzheimer's disease	0.000355	0.00185	CcSEcCtD
Nabumetone—Discomfort—Memantine—Alzheimer's disease	0.000354	0.00185	CcSEcCtD
Nabumetone—Dry mouth—Memantine—Alzheimer's disease	0.00035	0.00183	CcSEcCtD
Nabumetone—Asthenia—Galantamine—Alzheimer's disease	0.00035	0.00183	CcSEcCtD
Nabumetone—Anxiety—Rivastigmine—Alzheimer's disease	0.000349	0.00182	CcSEcCtD
Nabumetone—Confusional state—Memantine—Alzheimer's disease	0.000346	0.00181	CcSEcCtD
Nabumetone—Discomfort—Rivastigmine—Alzheimer's disease	0.000346	0.00181	CcSEcCtD
Nabumetone—PTGS2—forebrain—Alzheimer's disease	0.000344	0.0452	CbGeAlD
Nabumetone—Oedema—Memantine—Alzheimer's disease	0.000343	0.00179	CcSEcCtD
Nabumetone—Dry mouth—Rivastigmine—Alzheimer's disease	0.000342	0.00179	CcSEcCtD
Nabumetone—Insomnia—Donepezil—Alzheimer's disease	0.000342	0.00178	CcSEcCtD
Nabumetone—Paraesthesia—Donepezil—Alzheimer's disease	0.000339	0.00177	CcSEcCtD
Nabumetone—Confusional state—Rivastigmine—Alzheimer's disease	0.000338	0.00177	CcSEcCtD
Nabumetone—Shock—Memantine—Alzheimer's disease	0.000338	0.00176	CcSEcCtD
Nabumetone—Dyspnoea—Donepezil—Alzheimer's disease	0.000337	0.00176	CcSEcCtD
Nabumetone—Somnolence—Donepezil—Alzheimer's disease	0.000336	0.00175	CcSEcCtD
Nabumetone—Thrombocytopenia—Memantine—Alzheimer's disease	0.000336	0.00175	CcSEcCtD
Nabumetone—Oedema—Rivastigmine—Alzheimer's disease	0.000336	0.00175	CcSEcCtD
Nabumetone—Diarrhoea—Galantamine—Alzheimer's disease	0.000334	0.00174	CcSEcCtD
Nabumetone—Dyspepsia—Donepezil—Alzheimer's disease	0.000333	0.00174	CcSEcCtD
Nabumetone—Hyperhidrosis—Memantine—Alzheimer's disease	0.000332	0.00173	CcSEcCtD
Nabumetone—PTGS1—telencephalon—Alzheimer's disease	0.000331	0.0435	CbGeAlD
Nabumetone—Shock—Rivastigmine—Alzheimer's disease	0.00033	0.00172	CcSEcCtD
Nabumetone—Thrombocytopenia—Rivastigmine—Alzheimer's disease	0.000329	0.00171	CcSEcCtD
Nabumetone—Decreased appetite—Donepezil—Alzheimer's disease	0.000329	0.00171	CcSEcCtD
Nabumetone—Anorexia—Memantine—Alzheimer's disease	0.000327	0.00171	CcSEcCtD
Nabumetone—Fatigue—Donepezil—Alzheimer's disease	0.000326	0.0017	CcSEcCtD
Nabumetone—Hyperhidrosis—Rivastigmine—Alzheimer's disease	0.000324	0.00169	CcSEcCtD
Nabumetone—Constipation—Donepezil—Alzheimer's disease	0.000323	0.00169	CcSEcCtD
Nabumetone—Dizziness—Galantamine—Alzheimer's disease	0.000322	0.00168	CcSEcCtD
Nabumetone—Anorexia—Rivastigmine—Alzheimer's disease	0.00032	0.00167	CcSEcCtD
Nabumetone—PTGS2—telencephalon—Alzheimer's disease	0.000316	0.0416	CbGeAlD
Nabumetone—MPO—brain—Alzheimer's disease	0.000315	0.0414	CbGeAlD
Nabumetone—Feeling abnormal—Donepezil—Alzheimer's disease	0.000311	0.00162	CcSEcCtD
Nabumetone—Insomnia—Memantine—Alzheimer's disease	0.00031	0.00162	CcSEcCtD
Nabumetone—Vomiting—Galantamine—Alzheimer's disease	0.00031	0.00162	CcSEcCtD
Nabumetone—Gastrointestinal pain—Donepezil—Alzheimer's disease	0.000309	0.00161	CcSEcCtD
Nabumetone—Paraesthesia—Memantine—Alzheimer's disease	0.000308	0.00161	CcSEcCtD
Nabumetone—Rash—Galantamine—Alzheimer's disease	0.000307	0.0016	CcSEcCtD
Nabumetone—Dermatitis—Galantamine—Alzheimer's disease	0.000307	0.0016	CcSEcCtD
Nabumetone—Dyspnoea—Memantine—Alzheimer's disease	0.000306	0.0016	CcSEcCtD
Nabumetone—Headache—Galantamine—Alzheimer's disease	0.000305	0.00159	CcSEcCtD
Nabumetone—Somnolence—Memantine—Alzheimer's disease	0.000305	0.00159	CcSEcCtD
Nabumetone—Insomnia—Rivastigmine—Alzheimer's disease	0.000304	0.00158	CcSEcCtD
Nabumetone—Dyspepsia—Memantine—Alzheimer's disease	0.000302	0.00158	CcSEcCtD
Nabumetone—Paraesthesia—Rivastigmine—Alzheimer's disease	0.000301	0.00157	CcSEcCtD
Nabumetone—Urticaria—Donepezil—Alzheimer's disease	0.0003	0.00157	CcSEcCtD
Nabumetone—Dyspnoea—Rivastigmine—Alzheimer's disease	0.000299	0.00156	CcSEcCtD
Nabumetone—Abdominal pain—Donepezil—Alzheimer's disease	0.000299	0.00156	CcSEcCtD
Nabumetone—Body temperature increased—Donepezil—Alzheimer's disease	0.000299	0.00156	CcSEcCtD
Nabumetone—Somnolence—Rivastigmine—Alzheimer's disease	0.000298	0.00156	CcSEcCtD
Nabumetone—Decreased appetite—Memantine—Alzheimer's disease	0.000298	0.00156	CcSEcCtD
Nabumetone—Fatigue—Memantine—Alzheimer's disease	0.000296	0.00154	CcSEcCtD
Nabumetone—Dyspepsia—Rivastigmine—Alzheimer's disease	0.000295	0.00154	CcSEcCtD
Nabumetone—Constipation—Memantine—Alzheimer's disease	0.000293	0.00153	CcSEcCtD
Nabumetone—Decreased appetite—Rivastigmine—Alzheimer's disease	0.000292	0.00152	CcSEcCtD
Nabumetone—Nausea—Galantamine—Alzheimer's disease	0.00029	0.00151	CcSEcCtD
Nabumetone—Fatigue—Rivastigmine—Alzheimer's disease	0.000289	0.00151	CcSEcCtD
Nabumetone—Constipation—Rivastigmine—Alzheimer's disease	0.000287	0.0015	CcSEcCtD
Nabumetone—Feeling abnormal—Memantine—Alzheimer's disease	0.000283	0.00148	CcSEcCtD
Nabumetone—Gastrointestinal pain—Memantine—Alzheimer's disease	0.000281	0.00146	CcSEcCtD
Nabumetone—Hypersensitivity—Donepezil—Alzheimer's disease	0.000278	0.00145	CcSEcCtD
Nabumetone—Feeling abnormal—Rivastigmine—Alzheimer's disease	0.000277	0.00144	CcSEcCtD
Nabumetone—Gastrointestinal pain—Rivastigmine—Alzheimer's disease	0.000274	0.00143	CcSEcCtD
Nabumetone—Urticaria—Memantine—Alzheimer's disease	0.000273	0.00142	CcSEcCtD
Nabumetone—Abdominal pain—Memantine—Alzheimer's disease	0.000271	0.00142	CcSEcCtD
Nabumetone—Body temperature increased—Memantine—Alzheimer's disease	0.000271	0.00142	CcSEcCtD
Nabumetone—Asthenia—Donepezil—Alzheimer's disease	0.000271	0.00141	CcSEcCtD
Nabumetone—Pruritus—Donepezil—Alzheimer's disease	0.000267	0.0014	CcSEcCtD
Nabumetone—Urticaria—Rivastigmine—Alzheimer's disease	0.000267	0.00139	CcSEcCtD
Nabumetone—Abdominal pain—Rivastigmine—Alzheimer's disease	0.000265	0.00138	CcSEcCtD
Nabumetone—Body temperature increased—Rivastigmine—Alzheimer's disease	0.000265	0.00138	CcSEcCtD
Nabumetone—Naproxen—PTGS2—Alzheimer's disease	0.000263	0.0504	CrCbGaD
Nabumetone—Diarrhoea—Donepezil—Alzheimer's disease	0.000259	0.00135	CcSEcCtD
Nabumetone—Hypersensitivity—Memantine—Alzheimer's disease	0.000253	0.00132	CcSEcCtD
Nabumetone—Dizziness—Donepezil—Alzheimer's disease	0.00025	0.0013	CcSEcCtD
Nabumetone—Hypersensitivity—Rivastigmine—Alzheimer's disease	0.000247	0.00129	CcSEcCtD
Nabumetone—Asthenia—Memantine—Alzheimer's disease	0.000246	0.00128	CcSEcCtD
Nabumetone—Pruritus—Memantine—Alzheimer's disease	0.000243	0.00127	CcSEcCtD
Nabumetone—Asthenia—Rivastigmine—Alzheimer's disease	0.000241	0.00126	CcSEcCtD
Nabumetone—Vomiting—Donepezil—Alzheimer's disease	0.00024	0.00125	CcSEcCtD
Nabumetone—Rash—Donepezil—Alzheimer's disease	0.000238	0.00124	CcSEcCtD
Nabumetone—Dermatitis—Donepezil—Alzheimer's disease	0.000238	0.00124	CcSEcCtD
Nabumetone—Pruritus—Rivastigmine—Alzheimer's disease	0.000237	0.00124	CcSEcCtD
Nabumetone—Headache—Donepezil—Alzheimer's disease	0.000237	0.00124	CcSEcCtD
Nabumetone—Diarrhoea—Memantine—Alzheimer's disease	0.000235	0.00123	CcSEcCtD
Nabumetone—Diarrhoea—Rivastigmine—Alzheimer's disease	0.00023	0.0012	CcSEcCtD
Nabumetone—Dizziness—Memantine—Alzheimer's disease	0.000227	0.00118	CcSEcCtD
Nabumetone—Nausea—Donepezil—Alzheimer's disease	0.000224	0.00117	CcSEcCtD
Nabumetone—Dizziness—Rivastigmine—Alzheimer's disease	0.000222	0.00116	CcSEcCtD
Nabumetone—Vomiting—Memantine—Alzheimer's disease	0.000218	0.00114	CcSEcCtD
Nabumetone—Rash—Memantine—Alzheimer's disease	0.000216	0.00113	CcSEcCtD
Nabumetone—Dermatitis—Memantine—Alzheimer's disease	0.000216	0.00113	CcSEcCtD
Nabumetone—Headache—Memantine—Alzheimer's disease	0.000215	0.00112	CcSEcCtD
Nabumetone—Vomiting—Rivastigmine—Alzheimer's disease	0.000213	0.00111	CcSEcCtD
Nabumetone—Rash—Rivastigmine—Alzheimer's disease	0.000212	0.0011	CcSEcCtD
Nabumetone—Dermatitis—Rivastigmine—Alzheimer's disease	0.000211	0.0011	CcSEcCtD
Nabumetone—Headache—Rivastigmine—Alzheimer's disease	0.00021	0.0011	CcSEcCtD
Nabumetone—Nausea—Memantine—Alzheimer's disease	0.000204	0.00106	CcSEcCtD
Nabumetone—Nausea—Rivastigmine—Alzheimer's disease	0.000199	0.00104	CcSEcCtD
Nabumetone—PTGS1—nervous system—Alzheimer's disease	0.000195	0.0257	CbGeAlD
Nabumetone—PTGS1—central nervous system—Alzheimer's disease	0.000188	0.0247	CbGeAlD
Nabumetone—PTGS2—nervous system—Alzheimer's disease	0.000187	0.0245	CbGeAlD
Nabumetone—PTGS2—central nervous system—Alzheimer's disease	0.00018	0.0236	CbGeAlD
Nabumetone—PTGS2—cerebellum—Alzheimer's disease	0.000176	0.0231	CbGeAlD
Nabumetone—PTGS1—brain—Alzheimer's disease	0.000149	0.0196	CbGeAlD
Nabumetone—PTGS2—brain—Alzheimer's disease	0.000143	0.0188	CbGeAlD
Nabumetone—PTGS2—Integrated Pancreatic Cancer Pathway—EIF2AK2—Alzheimer's disease	0.00012	0.00237	CbGpPWpGaD
Nabumetone—PTGS2—Selenium Micronutrient Network—SOD2—Alzheimer's disease	0.000117	0.00232	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism of lipids and lipoproteins—PLD3—Alzheimer's disease	0.000117	0.00231	CbGpPWpGaD
Nabumetone—CYP1A2—Melatonin metabolism and effects—GSK3B—Alzheimer's disease	0.000115	0.00227	CbGpPWpGaD
Nabumetone—PTGS1—Selenium Micronutrient Network—F2—Alzheimer's disease	0.000114	0.00226	CbGpPWpGaD
Nabumetone—PTGS2—Spinal Cord Injury—NGFR—Alzheimer's disease	0.000111	0.00221	CbGpPWpGaD
Nabumetone—PTGS2—Integrated Pancreatic Cancer Pathway—MAPT—Alzheimer's disease	0.000111	0.00219	CbGpPWpGaD
Nabumetone—MPO—Selenium Micronutrient Network—IL6—Alzheimer's disease	0.000111	0.00219	CbGpPWpGaD
Nabumetone—CYP1A2—Aryl Hydrocarbon Receptor—LPL—Alzheimer's disease	0.000109	0.00216	CbGpPWpGaD
Nabumetone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—BAX—Alzheimer's disease	0.000108	0.00215	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism of lipids and lipoproteins—CYP46A1—Alzheimer's disease	0.000108	0.00213	CbGpPWpGaD
Nabumetone—PTGS2—Integrated Pancreatic Cancer Pathway—CST3—Alzheimer's disease	0.000108	0.00213	CbGpPWpGaD
Nabumetone—CYP1A2—Phase 1 - Functionalization of compounds—PTGS1—Alzheimer's disease	0.000107	0.00212	CbGpPWpGaD
Nabumetone—CYP1A2—Phase 1 - Functionalization of compounds—CYP2D6—Alzheimer's disease	0.000105	0.00208	CbGpPWpGaD
Nabumetone—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—MTHFR—Alzheimer's disease	0.000104	0.00207	CbGpPWpGaD
Nabumetone—PTGS1—Selenium Micronutrient Network—INS—Alzheimer's disease	0.000104	0.00205	CbGpPWpGaD
Nabumetone—PTGS2—Selenium Micronutrient Network—MTHFR—Alzheimer's disease	0.000103	0.00205	CbGpPWpGaD
Nabumetone—PTGS1—Selenium Micronutrient Network—CCL2—Alzheimer's disease	0.000102	0.00202	CbGpPWpGaD
Nabumetone—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Alzheimer's disease	0.000102	0.00201	CbGpPWpGaD
Nabumetone—PTGS2—Integrated Pancreatic Cancer Pathway—IAPP—Alzheimer's disease	0.000101	0.00199	CbGpPWpGaD
Nabumetone—PTGS2—Integrated Pancreatic Cancer Pathway—ACHE—Alzheimer's disease	9.88e-05	0.00196	CbGpPWpGaD
Nabumetone—PTGS2—Spinal Cord Injury—BDNF—Alzheimer's disease	9.69e-05	0.00192	CbGpPWpGaD
Nabumetone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CASP3—Alzheimer's disease	9.62e-05	0.0019	CbGpPWpGaD
Nabumetone—PTGS2—Spinal Cord Injury—IL1A—Alzheimer's disease	9.3e-05	0.00184	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism of lipids and lipoproteins—PLD3—Alzheimer's disease	9.26e-05	0.00183	CbGpPWpGaD
Nabumetone—PTGS2—Selenium Micronutrient Network—F2—Alzheimer's disease	9.08e-05	0.0018	CbGpPWpGaD
Nabumetone—PTGS2—Integrated Pancreatic Cancer Pathway—GSK3A—Alzheimer's disease	8.75e-05	0.00173	CbGpPWpGaD
Nabumetone—CYP1A2—Aryl Hydrocarbon Receptor—ESR1—Alzheimer's disease	8.74e-05	0.00173	CbGpPWpGaD
Nabumetone—PTGS2—Aryl Hydrocarbon Receptor—VEGFA—Alzheimer's disease	8.73e-05	0.00173	CbGpPWpGaD
Nabumetone—PTGS2—Integrated Pancreatic Cancer Pathway—APP—Alzheimer's disease	8.61e-05	0.0017	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism of lipids and lipoproteins—CYP46A1—Alzheimer's disease	8.55e-05	0.00169	CbGpPWpGaD
Nabumetone—PTGS1—Selenium Micronutrient Network—PTGS2—Alzheimer's disease	8.31e-05	0.00164	CbGpPWpGaD
Nabumetone—PTGS2—Selenium Micronutrient Network—INS—Alzheimer's disease	8.22e-05	0.00163	CbGpPWpGaD
Nabumetone—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—Alzheimer's disease	8.21e-05	0.00162	CbGpPWpGaD
Nabumetone—PTGS2—Selenium Micronutrient Network—CCL2—Alzheimer's disease	8.09e-05	0.0016	CbGpPWpGaD
Nabumetone—PTGS1—Selenium Micronutrient Network—IL1B—Alzheimer's disease	7.73e-05	0.00153	CbGpPWpGaD
Nabumetone—PTGS2—Spinal Cord Injury—LEP—Alzheimer's disease	7.61e-05	0.00151	CbGpPWpGaD
Nabumetone—CYP1A2—Biological oxidations—MAOB—Alzheimer's disease	7.52e-05	0.00149	CbGpPWpGaD
Nabumetone—PTGS2—Aryl Hydrocarbon Receptor—TNF—Alzheimer's disease	7.48e-05	0.00148	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—DHCR24—Alzheimer's disease	7.25e-05	0.00144	CbGpPWpGaD
Nabumetone—PTGS2—C-MYB transcription factor network—BCL2—Alzheimer's disease	7.21e-05	0.00143	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—DHCR24—Alzheimer's disease	7.19e-05	0.00142	CbGpPWpGaD
Nabumetone—PTGS2—Spinal Cord Injury—NOS2—Alzheimer's disease	7.09e-05	0.0014	CbGpPWpGaD
Nabumetone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—Alzheimer's disease	7e-05	0.00139	CbGpPWpGaD
Nabumetone—PTGS2—Disease—ITM2B—Alzheimer's disease	6.81e-05	0.00135	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism of lipids and lipoproteins—CHAT—Alzheimer's disease	6.7e-05	0.00133	CbGpPWpGaD
Nabumetone—PTGS2—Integrated Pancreatic Cancer Pathway—BDNF—Alzheimer's disease	6.59e-05	0.0013	CbGpPWpGaD
Nabumetone—PTGS2—Spinal Cord Injury—CCL2—Alzheimer's disease	6.4e-05	0.00127	CbGpPWpGaD
Nabumetone—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—Alzheimer's disease	6.27e-05	0.00124	CbGpPWpGaD
Nabumetone—PTGS2—Selenium Micronutrient Network—IL1B—Alzheimer's disease	6.14e-05	0.00121	CbGpPWpGaD
Nabumetone—PTGS2—Integrated Pancreatic Cancer Pathway—BAX—Alzheimer's disease	6.13e-05	0.00121	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—CA4—Alzheimer's disease	6.11e-05	0.00121	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism of lipids and lipoproteins—A2M—Alzheimer's disease	5.97e-05	0.00118	CbGpPWpGaD
Nabumetone—CYP1A2—Arachidonic acid metabolism—PTGS2—Alzheimer's disease	5.87e-05	0.00116	CbGpPWpGaD
Nabumetone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—Alzheimer's disease	5.83e-05	0.00115	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—GAPDHS—Alzheimer's disease	5.75e-05	0.00114	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—DHCR24—Alzheimer's disease	5.71e-05	0.00113	CbGpPWpGaD
Nabumetone—CYP1A2—Biological oxidations—PTGS1—Alzheimer's disease	5.7e-05	0.00113	CbGpPWpGaD
Nabumetone—PTGS1—Selenium Micronutrient Network—TNF—Alzheimer's disease	5.61e-05	0.00111	CbGpPWpGaD
Nabumetone—CYP1A2—Biological oxidations—CYP2D6—Alzheimer's disease	5.59e-05	0.00111	CbGpPWpGaD
Nabumetone—CYP1A2—Metapathway biotransformation—CYP2D6—Alzheimer's disease	5.51e-05	0.00109	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—ATP5A1—Alzheimer's disease	5.45e-05	0.00108	CbGpPWpGaD
Nabumetone—PTGS2—Disease—GAPDHS—Alzheimer's disease	5.45e-05	0.00108	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism of lipids and lipoproteins—CHAT—Alzheimer's disease	5.32e-05	0.00105	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—PLD3—Alzheimer's disease	5.24e-05	0.00104	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—PLD3—Alzheimer's disease	5.2e-05	0.00103	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism of lipids and lipoproteins—ACHE—Alzheimer's disease	5.2e-05	0.00103	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism of lipids and lipoproteins—INPP5D—Alzheimer's disease	5.14e-05	0.00102	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—HSD17B10—Alzheimer's disease	4.98e-05	0.000986	CbGpPWpGaD
Nabumetone—PTGS2—Integrated Pancreatic Cancer Pathway—ESR1—Alzheimer's disease	4.94e-05	0.000979	CbGpPWpGaD
Nabumetone—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—Alzheimer's disease	4.94e-05	0.000978	CbGpPWpGaD
Nabumetone—PTGS2—Spinal Cord Injury—IL1B—Alzheimer's disease	4.85e-05	0.000961	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—CA4—Alzheimer's disease	4.85e-05	0.000961	CbGpPWpGaD
Nabumetone—PTGS2—Spinal Cord Injury—CASP3—Alzheimer's disease	4.84e-05	0.000958	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—CYP46A1—Alzheimer's disease	4.84e-05	0.000958	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—CYP46A1—Alzheimer's disease	4.8e-05	0.000949	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism of lipids and lipoproteins—A2M—Alzheimer's disease	4.74e-05	0.000939	CbGpPWpGaD
Nabumetone—PTGS2—Disease—TTR—Alzheimer's disease	4.72e-05	0.000935	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—ND1—Alzheimer's disease	4.63e-05	0.000917	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—GAPDHS—Alzheimer's disease	4.56e-05	0.000903	CbGpPWpGaD
Nabumetone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—Alzheimer's disease	4.53e-05	0.000898	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism of lipids and lipoproteins—BCHE—Alzheimer's disease	4.53e-05	0.000896	CbGpPWpGaD
Nabumetone—PTGS1—Selenium Micronutrient Network—IL6—Alzheimer's disease	4.53e-05	0.000896	CbGpPWpGaD
Nabumetone—PTGS2—Selenium Micronutrient Network—TNF—Alzheimer's disease	4.45e-05	0.000881	CbGpPWpGaD
Nabumetone—PTGS2—Integrated Pancreatic Cancer Pathway—CREB1—Alzheimer's disease	4.45e-05	0.000881	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—ATP5A1—Alzheimer's disease	4.32e-05	0.000856	CbGpPWpGaD
Nabumetone—PTGS2—Integrated Pancreatic Cancer Pathway—IGF1—Alzheimer's disease	4.28e-05	0.000847	CbGpPWpGaD
Nabumetone—CYP1A2—Aryl Hydrocarbon Receptor—TNF—Alzheimer's disease	4.23e-05	0.000838	CbGpPWpGaD
Nabumetone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—Alzheimer's disease	4.23e-05	0.000838	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism of lipids and lipoproteins—ABCA1—Alzheimer's disease	4.14e-05	0.00082	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—PLD3—Alzheimer's disease	4.13e-05	0.000817	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism of lipids and lipoproteins—ACHE—Alzheimer's disease	4.13e-05	0.000817	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism of lipids and lipoproteins—INPP5D—Alzheimer's disease	4.08e-05	0.000807	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—HSD17B10—Alzheimer's disease	3.96e-05	0.000783	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism of lipids and lipoproteins—PTGS1—Alzheimer's disease	3.87e-05	0.000765	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—CYP46A1—Alzheimer's disease	3.81e-05	0.000754	CbGpPWpGaD
Nabumetone—PTGS2—Spinal Cord Injury—TGFB1—Alzheimer's disease	3.77e-05	0.000746	CbGpPWpGaD
Nabumetone—PTGS2—Integrated Pancreatic Cancer Pathway—BCL2—Alzheimer's disease	3.73e-05	0.000739	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—ND1—Alzheimer's disease	3.68e-05	0.000728	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism of lipids and lipoproteins—BCHE—Alzheimer's disease	3.59e-05	0.000712	CbGpPWpGaD
Nabumetone—PTGS2—Selenium Micronutrient Network—IL6—Alzheimer's disease	3.59e-05	0.000711	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism of lipids and lipoproteins—PPARGC1A—Alzheimer's disease	3.57e-05	0.000707	CbGpPWpGaD
Nabumetone—PTGS2—Spinal Cord Injury—TNF—Alzheimer's disease	3.52e-05	0.000697	CbGpPWpGaD
Nabumetone—PTGS2—Disease—SNCA—Alzheimer's disease	3.51e-05	0.000695	CbGpPWpGaD
Nabumetone—PTGS2—Integrated Pancreatic Cancer Pathway—CASP3—Alzheimer's disease	3.29e-05	0.000652	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism of lipids and lipoproteins—ABCA1—Alzheimer's disease	3.29e-05	0.000651	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism of lipids and lipoproteins—LPL—Alzheimer's disease	3.25e-05	0.000643	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—DHCR24—Alzheimer's disease	3.23e-05	0.000639	CbGpPWpGaD
Nabumetone—PTGS2—Disease—PSENEN—Alzheimer's disease	3.13e-05	0.000619	CbGpPWpGaD
Nabumetone—PTGS2—Spinal Cord Injury—TP53—Alzheimer's disease	3.1e-05	0.000615	CbGpPWpGaD
Nabumetone—PTGS2—Disease—APH1A—Alzheimer's disease	3.08e-05	0.000611	CbGpPWpGaD
Nabumetone—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK8—Alzheimer's disease	3.03e-05	0.000599	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—CHAT—Alzheimer's disease	3.01e-05	0.000596	CbGpPWpGaD
Nabumetone—PTGS2—Disease—NCSTN—Alzheimer's disease	3e-05	0.000595	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—CHAT—Alzheimer's disease	2.98e-05	0.000591	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—TPI1—Alzheimer's disease	2.98e-05	0.000591	CbGpPWpGaD
Nabumetone—PTGS2—Disease—LRP1—Alzheimer's disease	2.93e-05	0.00058	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—MAOB—Alzheimer's disease	2.86e-05	0.000567	CbGpPWpGaD
Nabumetone—PTGS2—Spinal Cord Injury—IL6—Alzheimer's disease	2.84e-05	0.000562	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism of lipids and lipoproteins—PPARGC1A—Alzheimer's disease	2.83e-05	0.000561	CbGpPWpGaD
Nabumetone—PTGS2—Disease—TPI1—Alzheimer's disease	2.83e-05	0.00056	CbGpPWpGaD
Nabumetone—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—Alzheimer's disease	2.79e-05	0.000553	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—GAPDH—Alzheimer's disease	2.75e-05	0.000545	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—CA4—Alzheimer's disease	2.75e-05	0.000544	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	2.72e-05	0.000539	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	2.7e-05	0.000534	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—A2M—Alzheimer's disease	2.68e-05	0.000531	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—A2M—Alzheimer's disease	2.66e-05	0.000527	CbGpPWpGaD
Nabumetone—PTGS2—Disease—EIF2AK2—Alzheimer's disease	2.66e-05	0.000527	CbGpPWpGaD
Nabumetone—PTGS2—Disease—GAPDH—Alzheimer's disease	2.61e-05	0.000517	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—GAPDHS—Alzheimer's disease	2.58e-05	0.000511	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism of lipids and lipoproteins—LPL—Alzheimer's disease	2.58e-05	0.000511	CbGpPWpGaD
Nabumetone—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—Alzheimer's disease	2.56e-05	0.000508	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—ATP5A1—Alzheimer's disease	2.45e-05	0.000484	CbGpPWpGaD
Nabumetone—PTGS2—Disease—PSEN2—Alzheimer's disease	2.44e-05	0.000484	CbGpPWpGaD
Nabumetone—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—Alzheimer's disease	2.39e-05	0.000474	CbGpPWpGaD
Nabumetone—PTGS2—Disease—CST3—Alzheimer's disease	2.39e-05	0.000473	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	2.37e-05	0.00047	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—TPI1—Alzheimer's disease	2.37e-05	0.000469	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—CHAT—Alzheimer's disease	2.37e-05	0.000469	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—PLD3—Alzheimer's disease	2.33e-05	0.000462	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—ACHE—Alzheimer's disease	2.33e-05	0.000462	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—ACHE—Alzheimer's disease	2.31e-05	0.000458	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—INPP5D—Alzheimer's disease	2.31e-05	0.000457	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—INPP5D—Alzheimer's disease	2.29e-05	0.000453	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—MAOB—Alzheimer's disease	2.27e-05	0.00045	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—HSD17B10—Alzheimer's disease	2.24e-05	0.000443	CbGpPWpGaD
Nabumetone—PTGS2—Disease—IAPP—Alzheimer's disease	2.23e-05	0.000442	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—PTGS1—Alzheimer's disease	2.19e-05	0.000433	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—GAPDH—Alzheimer's disease	2.19e-05	0.000433	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—ENO1—Alzheimer's disease	2.17e-05	0.000429	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	2.16e-05	0.000428	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—CYP46A1—Alzheimer's disease	2.15e-05	0.000427	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	2.14e-05	0.000424	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—CYP2D6—Alzheimer's disease	2.13e-05	0.000421	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—A2M—Alzheimer's disease	2.11e-05	0.000418	CbGpPWpGaD
Nabumetone—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—Alzheimer's disease	2.11e-05	0.000418	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—ND1—Alzheimer's disease	2.08e-05	0.000412	CbGpPWpGaD
Nabumetone—PTGS2—Disease—ENO1—Alzheimer's disease	2.06e-05	0.000407	CbGpPWpGaD
Nabumetone—PTGS2—Disease—PPP3CA—Alzheimer's disease	2.05e-05	0.000405	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—Alzheimer's disease	2.03e-05	0.000403	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—BCHE—Alzheimer's disease	2.02e-05	0.000399	CbGpPWpGaD
Nabumetone—PTGS2—Disease—GAB2—Alzheimer's disease	1.96e-05	0.000388	CbGpPWpGaD
Nabumetone—PTGS2—Disease—GSK3A—Alzheimer's disease	1.94e-05	0.000385	CbGpPWpGaD
Nabumetone—PTGS2—Disease—APP—Alzheimer's disease	1.91e-05	0.000378	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—PLCB1—Alzheimer's disease	1.9e-05	0.000377	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	1.88e-05	0.000373	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	1.87e-05	0.000369	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—ABCA1—Alzheimer's disease	1.86e-05	0.000368	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—ABCA1—Alzheimer's disease	1.84e-05	0.000365	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—ACHE—Alzheimer's disease	1.84e-05	0.000364	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—INPP5D—Alzheimer's disease	1.82e-05	0.00036	CbGpPWpGaD
Nabumetone—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—Alzheimer's disease	1.78e-05	0.000353	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—PTGS1—Alzheimer's disease	1.72e-05	0.000341	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—ENO1—Alzheimer's disease	1.72e-05	0.000341	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—CYP2D6—Alzheimer's disease	1.69e-05	0.000334	CbGpPWpGaD
Nabumetone—PTGS2—Disease—ADAM10—Alzheimer's disease	1.64e-05	0.000325	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—PPARGC1A—Alzheimer's disease	1.6e-05	0.000317	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—BCHE—Alzheimer's disease	1.6e-05	0.000317	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—PPARGC1A—Alzheimer's disease	1.59e-05	0.000315	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—HMOX1—Alzheimer's disease	1.58e-05	0.000313	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—PLCB1—Alzheimer's disease	1.51e-05	0.000299	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—ABCA1—Alzheimer's disease	1.46e-05	0.00029	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—LPL—Alzheimer's disease	1.46e-05	0.000289	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—LPL—Alzheimer's disease	1.45e-05	0.000286	CbGpPWpGaD
Nabumetone—PTGS2—Disease—LPL—Alzheimer's disease	1.37e-05	0.000272	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—CHAT—Alzheimer's disease	1.34e-05	0.000265	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—TPI1—Alzheimer's disease	1.34e-05	0.000265	CbGpPWpGaD
Nabumetone—PTGS2—Disease—PRKCG—Alzheimer's disease	1.33e-05	0.000264	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—MTHFR—Alzheimer's disease	1.3e-05	0.000258	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—MAOB—Alzheimer's disease	1.29e-05	0.000255	CbGpPWpGaD
Nabumetone—PTGS2—Disease—CCR5—Alzheimer's disease	1.26e-05	0.00025	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—PPARGC1A—Alzheimer's disease	1.26e-05	0.00025	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—HMOX1—Alzheimer's disease	1.26e-05	0.000249	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—GAPDH—Alzheimer's disease	1.24e-05	0.000245	CbGpPWpGaD
Nabumetone—PTGS2—Disease—MTHFR—Alzheimer's disease	1.23e-05	0.000244	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	1.22e-05	0.000242	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—CALM1—Alzheimer's disease	1.22e-05	0.000241	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—APOE—Alzheimer's disease	1.21e-05	0.00024	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	1.21e-05	0.00024	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—CAV1—Alzheimer's disease	1.2e-05	0.000238	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—A2M—Alzheimer's disease	1.2e-05	0.000237	CbGpPWpGaD
Nabumetone—PTGS2—Disease—CALM1—Alzheimer's disease	1.15e-05	0.000228	CbGpPWpGaD
Nabumetone—PTGS2—Disease—APOE—Alzheimer's disease	1.15e-05	0.000228	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—LPL—Alzheimer's disease	1.15e-05	0.000227	CbGpPWpGaD
Nabumetone—PTGS2—Disease—CAV1—Alzheimer's disease	1.14e-05	0.000226	CbGpPWpGaD
Nabumetone—PTGS2—Disease—NOS2—Alzheimer's disease	1.07e-05	0.000212	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	1.07e-05	0.000211	CbGpPWpGaD
Nabumetone—PTGS2—Disease—NOTCH1—Alzheimer's disease	1.06e-05	0.00021	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—PPARG—Alzheimer's disease	1.06e-05	0.000209	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—ACHE—Alzheimer's disease	1.04e-05	0.000206	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—INS—Alzheimer's disease	1.04e-05	0.000205	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—MTHFR—Alzheimer's disease	1.03e-05	0.000205	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—INPP5D—Alzheimer's disease	1.03e-05	0.000203	CbGpPWpGaD
Nabumetone—PTGS2—Disease—GSK3B—Alzheimer's disease	9.96e-06	0.000197	CbGpPWpGaD
Nabumetone—PTGS2—Disease—CREB1—Alzheimer's disease	9.88e-06	0.000196	CbGpPWpGaD
Nabumetone—PTGS2—Disease—INS—Alzheimer's disease	9.82e-06	0.000194	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—ENO1—Alzheimer's disease	9.74e-06	0.000193	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—PTGS1—Alzheimer's disease	9.74e-06	0.000193	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—CALM1—Alzheimer's disease	9.66e-06	0.000191	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—APOE—Alzheimer's disease	9.63e-06	0.000191	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—CYP2D6—Alzheimer's disease	9.55e-06	0.000189	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—CAV1—Alzheimer's disease	9.54e-06	0.000189	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—NOS3—Alzheimer's disease	9.09e-06	0.00018	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—BCHE—Alzheimer's disease	9.06e-06	0.000179	CbGpPWpGaD
Nabumetone—PTGS2—Disease—NOS3—Alzheimer's disease	8.61e-06	0.000171	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—PLCB1—Alzheimer's disease	8.55e-06	0.000169	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—PPARG—Alzheimer's disease	8.39e-06	0.000166	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	8.38e-06	0.000166	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—PTGS2—Alzheimer's disease	8.31e-06	0.000165	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—ABCA1—Alzheimer's disease	8.28e-06	0.000164	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—INS—Alzheimer's disease	8.23e-06	0.000163	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—NOS3—Alzheimer's disease	7.21e-06	0.000143	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—PPARGC1A—Alzheimer's disease	7.14e-06	0.000141	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—HMOX1—Alzheimer's disease	7.11e-06	0.000141	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—LPL—Alzheimer's disease	6.5e-06	0.000129	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—MTHFR—Alzheimer's disease	5.85e-06	0.000116	CbGpPWpGaD
Nabumetone—PTGS2—Disease—TGFB1—Alzheimer's disease	5.7e-06	0.000113	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—CALM1—Alzheimer's disease	5.47e-06	0.000108	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—APOE—Alzheimer's disease	5.45e-06	0.000108	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—CAV1—Alzheimer's disease	5.4e-06	0.000107	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—PPARG—Alzheimer's disease	4.75e-06	9.4e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—INS—Alzheimer's disease	4.65e-06	9.22e-05	CbGpPWpGaD
Nabumetone—PTGS2—Disease—IL6—Alzheimer's disease	4.29e-06	8.5e-05	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—AKT1—Alzheimer's disease	4.18e-06	8.27e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—NOS3—Alzheimer's disease	4.08e-06	8.08e-05	CbGpPWpGaD
Nabumetone—PTGS2—Disease—AKT1—Alzheimer's disease	3.96e-06	7.84e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—PTGS2—Alzheimer's disease	3.73e-06	7.39e-05	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—AKT1—Alzheimer's disease	3.32e-06	6.56e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—AKT1—Alzheimer's disease	1.88e-06	3.71e-05	CbGpPWpGaD
